Table 2 Prevalence of rifampicin-resistant M. tuberculosis in each variable among the total M. tuberculosis cases using Gene Xpert MTB/RIF assay, DMRH, 2015
Variables | Resistance pattern | P value | |
|---|---|---|---|
Resistance N (%) | Sensitive N (%) | ||
Age, years | |||
 ≤10 | 2 (22.2) | 7 (77.8) | 0.02 |
 11–17 | 1(14.3) | 6 (83.6) |  |
 18–30 | 3 (6.7) | 43 (93.3) |  |
 31–40 | 0 | 25 (100) |  |
 41–50 | 5 (33.3) | 10 (66.7) |  |
 51–60 | 0 | 9 (100) |  |
 61–92 | 1 (16.7) | 5 (83.3) |  |
Sex | |||
 Male | 8 (11.3) | 64 (88.7) | 0.77 |
 Female | 4 (8.9) | 41 (91.1) |  |
Residence | |||
 Urban | 5 (17.9) | 53 (91.2) | 0.76 |
 Rural | 7 (11.9) | 52 (88.1) |  |
HIV infection | |||
 Positive | 5 (17.9) | 24 (82.1) | 0.17 |
 Negative | 7 (8) | 81 (92) |  |
Reason for diagnosis | |||
 Presumptive TB | 3 (5.9) | 49 (94.1) | 0.22 |
 Presumptive DR TB | 9 (13.8) | 56 (86.2) |  |
Treatment history with anti-TB drugs | |||
 Previously treated | 7 (17.1) | 34 (82.9) | 0.11 |
 Previously untreated | 5 (6.7) | 71 (93.3) |  |
Presumptive DR TB | |||
 New | 3 (10.7) | 25 (89.3) | 0.87 |
 Relapse | 5 (19.2) | 21 (80.8) |  |
 Failure | 2 (14.3) | 12 (91.7) |  |
 MDR-contact | 0 | 1 |  |
Site of presumptive TB | |||
 Pulmonary | 6 (9.4) | 58 (90.6) | 0.77 |
 Extra pulmonary | 6 (11.3) | 47 (88.7) |  |
Specimen type | |||
 Respiratory (sputum) | 6 (9.5) | 58 (90.6) | 0.67 |
 Non-respiratory | 6 (11.3) | 47 (88.7) |  |
Type of non-respiratory specimen | |||
 Pus | 4 (8.5) | 43 (91.5) |  |
 Peritoneal fluid | 0 | 2 |  |
 Lymph node aspirate | 0 | 1 |  |
 Pleural fluid | 2 | 1 |  |
Total | 12 (10.3) | 105 (89.7) | Â |